KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Cash from Operations (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Cash from Operations data on record, last reported at 147520000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations fell 7.43% year-over-year to 147520000.0; the TTM value through Dec 2025 reached 737646000.0, changed 0.42%, while the annual FY2025 figure was 737646000.0, 0.42% changed from the prior year.
  • Cash from Operations reached 147520000.0 in Q4 2025 per CRL's latest filing, down from 213826000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 251792000.0 in Q3 2024 and bottomed at 102630000.0 in Q1 2022.
  • Average Cash from Operations over 5 years is 176828000.0, with a median of 173209500.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: surged 148.18% in 2021, then tumbled 39.71% in 2022.
  • A 5-year view of Cash from Operations shows it stood at 229258000.0 in 2021, then grew by 2.4% to 234757000.0 in 2022, then fell by 5.88% to 220943000.0 in 2023, then fell by 27.87% to 159362000.0 in 2024, then dropped by 7.43% to 147520000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 147520000.0 in Q4 2025, 213826000.0 in Q3 2025, and 204603000.0 in Q2 2025.